Restrictions on obesity drug coverage force patients to pivot

Meghan Lena was devastated when she lost coverage for her obesity medication.

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.

(Image credit: Jodi Hilton for NPR)

Source Author
Author: Source Author

Written by

Sydney Lupkin

in

More posts